Problem is MK has lied so many times about so many things, the market doesn't believe any good news like MK's unverified BDD claim. But the market certainly believes the bad news, and there's been plenty of bad news out of RDGL for over a year now.
MK continuing to waste most of his time on hopeless IsoPet is bad news.
The continued delays for the Mayo certification training is bad news.
MK still messing with basic manufacturing issues like gel shelf life and filtration is very, very bad news. It means RDGL isn't even close to meeting FDA GMP standards, which in turn means they're nowhere close to human trials.
MK's claims of IP protection via a weak process patent is bogus and further damages his credibility. All the original patents have expired. There are no IP barriers to entry.
One could go on and on with the bad news turds that MK continues to drop.
Dr. Beau Toskich's Tweet yesterday promoting a a different Y90 brachytherapy (a radioembolization product) was further bad news that may indicate he's no longer working with RDGL.
Situation is what it is.
News 
Market Data 
Discover 
AI
